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Abstract Micronemes and rhoptries are specialized secretory organelles that deploy their
contents at the apical tip of apicomplexan parasites in a regulated manner. The secretory proteins
participate in motility, invasion, and egress and are subjected to proteolytic maturation prior to
organellar storage and discharge. Here we establish that Toxoplasma gondii aspartyl protease 3
(ASP3) resides in the endosomal-like compartment and is crucially associated to rhoptry discharge
during invasion and to host cell plasma membrane lysis during egress. A comparison of the
N-terminome, by terminal amine isotopic labelling of substrates between wild type and ASP3
depleted parasites identified microneme and rhoptry proteins as repertoire of ASP3 substrates.
The role of ASP3 as a maturase for previously described and newly identified secretory proteins is
confirmed in vivo and in vitro. An antimalarial compound based on a hydroxyethylamine scaffold
interrupts the lytic cycle of T. gondii at submicromolar concentration by targeting ASP3.
DOI: https://doi.org/10.7554/eLife.27480.001
Introduction
Members of the Apicomplexa phylum include obligate intracellular parasites that are responsible for
severe diseases in humans and farm animals. Toxoplasma gondii infection can be lethal for immuno-
compromised individuals, while infection in pregnant women can lead to birth defects or miscar-
riage. P. falciparum is responsible for the most life-threatening form of malaria and globally is one of
the top ten causes of death with half the world’s population currently at risk. Additionally, other Api-
complexans such as Cryptosporidium, Eimeria, Theileria and Babesia spp. infect farm animals and
are responsible for considerable economic losses. No efficient vaccines or eradicating drug treat-
ments are available against this important group of pathogens.
Invasion and egress are two key steps in the lytic cycle of Apicomplexa as they go through com-
plex life stage development in one or multiple hosts (Dubey et al., 1998). The sequential and regu-
lated discharge of protein factors from two apical secretory organelles called micronemes and
rhoptries is essential for parasite survival and for dissemination of the infection in the host
(Carruthers and Sibley, 1997). The content of these two types of organelles includes notably adhe-
sins, perforins, proteases, lipases and kinases that are critical for motility, host attachment, formation
of the parasitophorous vacuole membrane (PVM) during invasion and for lysis of the PVM and host
plasma membrane upon egress (Kemp et al., 2013; Roiko and Carruthers, 2009). The microneme
(MICs), rhoptry neck (RONs) and rhoptry bulb (ROPs) proteins are produced late during the parasite
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cell cycle and undergo extensive proteolytic maturation in an endosomal-like compartment (ELC)
along their trafficking from the Golgi to their respective target organelles (Nishi et al., 2008).
MICs typically exist as complexes composed of adhesive and transmembrane domain-containing
proteins that are discharged onto the parasite surface at the apical tip. Some of these complexes
engage with host receptors and translocate to the posterior end of the parasite, hence mediating
gliding motility and invasion. The characterized complexes to date include MIC2-M2AP (MIC2-asso-
ciated protein) involved in gliding motility (Huynh and Carruthers, 2006; Huynh et al., 2003),
MIC6-MIC1-MIC4 contributing to parasite attachment and invasion (Reiss et al., 2001), and MIC3-
MIC8 associated with rhoptry secretion (Ce´re`de et al., 2002; Kessler et al., 2008). The majority of
the MICs undergo extensive pre- and post-exocytosis proteolytic processing. Intracellular processing
occurs post-Golgi and prior to the storage in the micronemes. The MIC pro-domains have been
implicated in facilitating traffic to microneme organelles. A propeptide deletion mutant of M2AP is
retained in the post-Golgi region, hampering its trafficking to the micronemes (Harper et al., 2006).
While the cleavage mutant of M2AP shows normal trafficking to micronemes, the removal of the
pro-domain appears to be important for MIC2-M2AP complex formation and secretion
(Harper et al., 2006). The first of the three EGF-like domains of MIC6 is cleaved off, but this event
does not impact on the MIC1-MIC4-MIC6 complex formation and trafficking (Reiss et al., 2001).
Similarly, MIC3, MIC5 and M2AP are processed prior to reaching the micronemes (Brydges et al.,
2000; Ce´re`de et al., 2002; Rabenau et al., 2001). Once on the parasite surface, the transmem-
brane MICs, are shed by the microneme protein protease 1 (MPP1) activity that has been attributed
to rhomboid protease dependent intramembrane proteolysis (Rugarabamu et al., 2015;
Shen et al., 2014b). In addition, the MPP2 activity mediated by the action of subtilisin protease
SUB1 (SUB1) also participates in post-exocytosis processing of the MICs (Lagal et al., 2010;
Saouros et al., 2012). The protease responsible for the pre-exocytosis processing of these secreted
proteins has not been identified to date, although the presence of cathespin L (CPL) is required for
optimal processing (Parussini et al., 2010).
Following attachment and apical reorientation of the parasite towards the host cell, the rhoptries’
membranous material and proteins are directly discharged into the host cell cytosol during parasite
entry (Carruthers and Boothroyd, 2007). A subset of proteins at the neck of the rhoptries, termed
rhoptry neck proteins (RONs) form a complex (RON2-4-5-8) that is anchored into the host cell mem-
brane and associated with the microneme protein AMA1 on the parasite surface (Alexander et al.,
2005; Besteiro et al., 2009; Lebrun et al., 2005). This AMA1-RONs complex plays a central role in
moving junction (MJ) formation and host cell entry (Bargieri et al., 2013; Lamarque et al., 2014;
Mital et al., 2005). The MJ presumably serves as a support for the propulsion of the parasite into
the host cell powered by the actomyosin system and the connector GAC (Jacot et al., 2016). The
rhoptry bulb proteins (ROPs), on the other hand, act as effectors and subvert host cellular functions
by either interacting with the PVM to protect the parasites against host defense and clearance mech-
anisms or trafficking to the host nucleus to reprogram gene expression (Bradley et al., 2005;
Ha˚kansson et al., 2001). Many ROPs contain kinase and pseudokinase domains (El Hajj et al.,
2006; Peixoto et al., 2010) and act as key virulence factors such as ROP18, which along with ROP5
promotes parasite survival in mice by inactivating immunity-related GTPase (IRGs) by phosphoryla-
tion (Niedelman et al., 2012) and ROP16, which interacts with the host cell STAT signaling cascade,
phosphorylating STAT3/STAT6 and suppressing TLR signaling (Ong et al., 2010; Saeij et al., 2007;
Yamamoto et al., 2009).
Most of the rhoptry proteins are synthesized with an N-terminal pro-domain subsequently cleaved
in a post-Golgi compartment. The ROPs, in particular, contain a putative cleavage site with the con-
sensus sequence SjXE (j is hydrophobic, X is any amino acid), and presumably processed by the
rhoptry subtilisin SUB2 within the immature rhoptries of nascent daughter parasites (Miller et al.,
2003). The cleavage site has been experimentally confirmed only for ROP1, ROP13 and SUB2
(Bradley and Boothroyd, 1999; Miller et al., 2003; Soldati et al., 1998; Turetzky et al., 2010).
Though the pro-domain of ROP1 is shown to be sufficient for rhoptry targeting, the removal of the
pro-domain does not appear to affect its targeting to the organelles (Bradley et al., 2002;
Miller et al., 2003; Turetzky et al., 2010) and few of the ROPs, e.g. ROP5, are not processed dur-
ing their trafficking. RONs are also extensively processed along the secretory pathway, and have
SjXE consensus motifs within their sequences (Besteiro et al., 2009), however, the proteases impli-
cated in their maturation are not known.
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T. gondii encodes 7 aspartyl proteases (ASPs), with only ASP1, ASP3 and ASP5 being significantly
expressed in the tachyzoite stage. Among these, ASP1 is coccidian-specific and dispensable in tissue
culture as well as in the mouse model of infection (Polonais et al., 2011). The Golgi-associated
aspartyl protease ASP5 has recently been associated to the establishment of the intravacuolar net-
work and the trafficking of effectors to the PVM and beyond (Coffey et al., 2015; Curt-
Varesano et al., 2016; Hammoudi et al., 2015).
Herein, we report the functional dissection of ASP3 and demonstrate its essential nature for inva-
sion and egress from the host cells. We exploited the power of a proteomics pipeline based on the
novel terminal amine isotopic labelling of substrates (TAILS) technology (Kleifeld et al., 2010;
Kleifeld et al., 2011) to compare the N-terminome of wild type and ASP3-depleted parasites. The
TAILS analysis identified the repertoire of ASP3 substrates and revealed that ASP3 acts as maturase
for ROPs, RONs and MICs along their trafficking route from Golgi to their respective organelles. We
validated a series of known as well as novel ASP3 substrates both in vivo and in vitro toward a
molecular understanding of the dramatic phenotype of ASP3 depletion in invasion and egress.
Importantly, a hydroxyethylamine scaffold based compound, 49c, disrupts the T. gondii lytic cycle by
inhibiting ASP3 at submicromolar concentration.
Results
ASP3 is a post-Golgi resident aspartyl protease essential for invasion
and egress
In the phylum of Apicomplexa, aspartyl proteases cluster into 6 distinct clades (Figure 1—figure
supplement 1). Members of this class of proteases exhibit two catalytic aspartic acid residues (con-
served motifs DTG or DTG/DSG), a polyproline loop and a flap predicted to close over the active
site, thereby influencing substrate binding. (Figure 1—figure supplement 2). ASP3 groups together
with two phylogenetically related genes in the subgroup Haemosporidia, that correspond to Plas-
mepsin IX and X (PMIX and PMX) in the malaria parasites. To characterize ASP3, we first tagged C--
terminally its endogenous locus with 3xty tag (Figure 1—figure supplement 3). Western blot
analysis (WB) of the tagged strain (ASP3ty) revealed two major forms, a band at ~70 kDa corre-
sponding to the predicted full-length protein, and a 50 kDa processed form of the enzyme
(Figure 1A). Ectopically expressed ASP3 was previously localized to a post-Golgi compartment
(Shea et al., 2007), which was confirmed in the ASP3ty strain (Figure 1B). Indirect immunofluores-
cence analysis (IFA) using markers for various compartments of the secretory pathway (GRASP – cis-
Golgi, DrpB – post-Golgi, proM2AP – ELC) revealed that ectopically expressed ASP3 localizes in the
vicinity of the ELC and beyond (Breinich et al., 2009; Harper et al., 2006). Since ASP3 did not co-
localize perfectly with any of these markers, we conclude that the enzyme is likely to be present in
more than one subcompartment (Figure 1B–C).
ASP3 was refractory to gene excision (data not shown) and in consequence, we generated a con-
ditional knockdown of ASP3 by endogenous promoter swap with a tet-repressible promoter. The
genotypes of the resulting three independent strains (ASP3-iKD, ASP3ty-iKD and ASP3myc-iKD)
were confirmed by genomic PCR analysis (Figure 1—figure supplements 3 and 4). The tightness of
anhydrotetracycline (ATc)-dependent expression in ASP3ty-iKD and ASP3myc-iKD parasites was
assessed by WB (Figure 1A and Figure 1—figure supplement 6A). Plaque assays performed on the
ASP3myc-iKD parasites (Figure 1D) incubated with or without ATc for 7 days exhibited no plaque
formation in absence of ASP3 indicating a severe defect in one or several steps of the lytic cycle and
the same phenotype was observed with ASP3ty-iKD (data not shown). Complementation of
ASP3myc-iKD with a second copy of ASP3ty fully rescued the lethality in the presence of ATc, while
a catalytically dead mutant of ASP3 (asp3ty-D299A) failed to rescue (Figure 1D and Figure 1—fig-
ure supplement 5). Interestingly, asp3ty-D299A is only weakly processed in the absence of ATc
whereas the processing completely disappeared upon ASP3 depletion, suggesting an autocatalytic
maturation process (Figure 1—figure supplement 6A–B).
A deeper investigation of each steps of the lytic cycle revealed that ASP3 depletion did not affect
parasite intracellular growth, parasite attachment or gliding motility whereas invasion and induced
egress were severely impaired (Figure 1E–I). The mitochondrion and apicoplast appear morphologi-
cally normal in absence of ASP3 (Figure 1—figure supplement 6C). Relevantly, ASP3-depleted
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Figure 1. ASP3 is present in the secretory pathway and is essential for invasion and egress. (A) Ty-tagged endogenous ASP3 (ASP3ty) expression and
tight regulation of ASP3ty tet-inducible knockdown (ASP3ty-iKD -/+ATc) assessed by western blot. Catalase was used as loading control. (B) ASP3
localizes to a post-Golgi compartment. (C) Ty-tagged ASP3 expressed from a tubulin promoter partially colocalized with GRASP-YFP, proM2AP and
DrpB. (D) ASP3 depletion results in drastic impairment of the lytic cycle, as assessed by plaque formation after 7 days, in the presence of ATc.
Complementation with a second WT copy of ASP3 (ASP3ty) fully restored plaque formation whereas complementation with a catalytically dead mutant
(asp3ty-D299A) could not. ASP3 depleted parasites (24 or 48 hr +ATc) showed no defect in E) intracellular replication and in F) attachment, but showed
a strong defect in G) invasion and H) egress compared to control RHDku80 (48 hr +ATc) or non-treated ASP3ty-iKD parasites. Data are presented as
mean ±standard deviation (SD) from 3 independent experiments. (I) ASP3 depleted parasite (48 hr +ATc) showed no defect in gliding motility. Gliding
trails are detected using anti-SAG1 antibodies. (J) Western blot analyses of excreted-secreted antigens (ESA) and pellets from ASP3ty-iKD parasites, +/
 ATc, after stimulation with 2% Ethanol (EtOH) showed normal secretion of the microneme proteins MIC2 and AMA1. Full length and secreted
fragments are showed with arrowheads. Catalase was used as cytosolic control and GRA1 for constitutive secretion. (K) ASP3 depletion resulted in a
complete absence of rhoptry content secretion as assessed by evacuole formation by probing against the rhoptry protein ROP1. (L) The formation of
the MJ was assessed by the specific labelling of secreted RON4 and showed to be dependent on the presence of ASP3. This was independent of
cytochalasin D treatment. Data are represented as mean ±standard deviation of three independent biological replicate experiments. All scale bars
throughout represent 8 mm.
DOI: https://doi.org/10.7554/eLife.27480.002
Figure 1 continued on next page
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parasites showed delayed exit from the host cells upon both natural and induced egress by live
microscopy. Motile parasites were trapped in spherical detached host cells and eventually rupturing
the host PM (Figure 1—figure supplement 6D, Videos 1–3). This egress defect is reminiscent of
the reported phenotype in parasites lacking the microneme perforin, PLP1 (Kafsack et al., 2009).
Freshly egressed ASP3ty-iKD and WT parasites, pre-treated or not with ATc, were stimulated
with 2% ethanol to induce micronemes secretion. The resulting excreted secreted antigens (ESA)
fractions were analyzed by WB and revealed no significant alteration in microneme secretion. The
dense granule protein, GRA1, and the cytosolic catalase, CAT, served as controls for parasite viabil-
ity and parasite lysis, respectively (Figure 1J).
Rhoptry discharge can be assessed by analysis of empty vacuoles (evacuoles) formation in pres-
ence of cytochalasin D (cytD), an actin polymerization inhibitor known to block motility and invasion
without impairing microneme and rhoptry secretion (Ha˚kansson et al., 2001; Kessler et al., 2008).
The injection of the rhoptry content in host cells is detectable by IFA using antibodies recognizing
the rhoptry protein ROP1. Strikingly, parasites depleted in ASP3 failed to produce evacuoles
(Figure 1K). The secretion of RONs can be mon-
itored by assessing MJ formation by IFA on 0.1%
Figure 1 continued
The following source data and figure supplements are available for figure 1:
Source data 1. Source data of the triplicate experiments done on the ASP tet-inducible knockdown strains (-ATc, +ATc 24 hr and +ATc 48 hr) for Intra-
cellular growth assay (E), Host cell attachment assay (F), Invasion assay (G), Egress assay (H) and quantification of MJs (L).
DOI: https://doi.org/10.7554/eLife.27480.009
Figure supplement 1. Phylogenetic clustering of apicomplexan aspartyl proteases.
DOI: https://doi.org/10.7554/eLife.27480.003
Figure supplement 2. T. gondii aspartyl proteases and its P. falciparum homologs.
DOI: https://doi.org/10.7554/eLife.27480.004
Figure supplement 3. Strategy for epitope tagging at the endogenous locus.
DOI: https://doi.org/10.7554/eLife.27480.005
Figure supplement 4. Generation of the tet-inducible ASP3 strains.
DOI: https://doi.org/10.7554/eLife.27480.006
Figure supplement 5. Complementation in tet-inducible ASP3 strain with WT ASP3ty and the catalytically dead mutant asp3ty-D299A.
DOI: https://doi.org/10.7554/eLife.27480.007
Figure supplement 6. Phenotyping of ASP3 depleted parasites.
DOI: https://doi.org/10.7554/eLife.27480.008
Video 1. ASP3 depleted parasites display impaired
egress. During egress from host cell, ASP3 depleted
parasites were often found trapped in floating spherical
membranous structures. The parasites are very motile
within these structures and attempt to mechanically
rupture the membranes with most eventually escaping.
DOI: https://doi.org/10.7554/eLife.27480.010
Video 2. ASP3 depleted parasites display impaired
egress. During egress from host cell, ASP3 depleted
parasites were often found trapped in floating spherical
membranous structures.
DOI: https://doi.org/10.7554/eLife.27480.011
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saponin permeabilized parasites. In ASP3-depleted parasites, RON4 was absent at the junction in
more than 90% of parasites, with or without prior cytD treatment (Figure 1L and Figure 1—figure
supplement 6E). Collectively, these results reveal that ASP3 is necessary for the lysis of the host PM
and for rhoptry content discharge, explaining the severe blocks in egress and invasion respectively.
Identification of ASP3 substrates using N-terminome analysis
The phenotypic consequences of ASP3 depletion suggest that this protease contributes to the proc-
essing of proteins implicated in rhoptry discharge and host PM lysis. Given its localization in the
vicinity of the ELC, we hypothesized a plausible role as maturase for MICs, ROPs and RONs, known
to undergo maturation along the secretory pathway, prior to accumulation in their respective secre-
tory organelles. To determine the in vivo repertoire of ASP3 substrates and their precise cleavage
sites, we quantitatively compared the N-terminome of ASP3ty-iKD parasites +ATc/-ATc using Termi-
nal Amine Isotopic Labelling of Substrates (TAILS) (Figure 2—figure supplement 1) (Kleifeld et al.,
2010; Kleifeld et al., 2011). The TAILS datasets yielded 32594 peptide spectrum match (PSM),
which could be assigned to 9169 T. gondii-specific peptide groups representing 1529 proteins con-
tained in ToxoDB. Among the identified peptides, we found 1487 N-terminal peptides (~16%) sup-
ported by 8103 PSMs. 615 of these terminal peptides were acetylated (supported by 2597 PSMs)
and therefore represent natural N-termini. The remaining 872 peptide groups were labelled with
TMT on the alpha amine group (Figure 2A). As expected, the total proteome (pre-TAILS data, 1236
annotated proteins) overlapped with the proteins identified by the TAILS dataset (887 proteins), but
enrichment for N-terminal peptides also identified 293 additional proteins (Figure 2B). Normalized
log2 abundance ratios (+ATc/-ATc) were calculated for each peptide group to identify ASP3-depen-
dent cleavages.
Among the 872 labelled peptide groups, we identified 65 showing either <0.22 or >2 +ATc/-ATc
ratios in the ASP3 depleted condition, representing 17 and 29 proteins (41 unique proteins com-
bined), respectively (Figure 2C, Table 1, Supplementary files 1 and 3). 26 of the 41 unique proteins
with putative ASP3-dependent processing profiles are annotated as secreted proteins in ToxoDB. A
more relaxed +ATc/-ATc ratio threshold of <0.5 expanded this candidate dataset by 42 proteins to
59 (Supplementary file 2). Strikingly, concordant with the egress and invasion phenotypes of ASP3
depletion, the majority of proteins are annotated as MICs, RONs and ROPs, some of which were
previously shown to be processed post-Golgi. (Detailed analysis of the TAILS and the criteria for sub-
strate selection is described in Appendix 1).
ASP3 is necessary for the processing of a subset of microneme proteins
To validate the ASP3 substrates deduced from the TAILS analysis, we examined previously character-
ized MICs, known to be processed, by WB in ASP3ty-iKD +/-ATc. In agreement with the TAILS data,
M2AP, MIC3 and MIC6 accumulated as unprocessed forms at 24 hr post ATc treatment whereas
MIC2, MIC4, CPL and MIC8 are not affected (Figure 3A–B and Figure 3—figure supplement 1A).
However, the organellar targeting of these unprocessed MICs remained unchanged (Figure 3G and
Figure 3—figure supplement 1B). This is evident when using antibodies raised against the pro-
domain of M2AP, which only stain the ELC in wild type parasites but atypically detect the unpro-
cessed M2AP in the micronemes in ASP3 depleted parasites (Figure 3G). The defect in processing is
rescued by expressing a second copy of wild type ASP3 but not the catalytically dead mutant
asp3ty-D299A, as shown for MIC6 (Figure 3C).
MIC8 has previously been reported to be necessary for invasion, selectively participating in rhop-
try discharge by an unknown mechanism (Kessler et al., 2008). Since MIC8 is not processed pre-
exocytosis (Meissner et al., 2002) and neither the trafficking nor secretion is unaffected in ASP3ty-
iKD parasites (Figure 3—figure supplement 1B–C), ASP3-dependent impairment in rhoptry dis-
charge is unlikely to be explained by a defect in MIC8 function.
In contrast to the other MICs, MIC5, which was absent in the TAILS analysis, is processed normally
in ASP3 depleted parasites, suggesting the existence of an alternate protease acting as maturase for
a subset of MICs (Figure 3D). In this context, toxolysin 4 (TLN4) is a metalloproteinase stored in the
micronemes, extensively processed prior to secretion and previously reported to participate in inva-
sion and egress (Laliberte´ and Carruthers, 2011). When expressed as a HA-tagged second copy in
ASP3ty-iKD, TLN4 exhibited an altered pattern of processing upon ASP3 depletion (Figure 3E).
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PLP1 is the only microneme protein implicated
in egress and for which a peptide is found
enriched in the TAILS data set, which is consistent
with the reported N-terminal processing of PLP1
prior to exocytosis (Kafsack et al., 2009;
Lagal et al., 2010). Since parasites lacking PLP1
remain trapped into host cells and still sur-
rounded by the PMV, we also assessed the proc-
essing of PLP1 in ASP3ty-iKD +/-ATc by
C-terminal tagging at the endogenous locus. The
processing of PLP1 was difficult to assess by
western blot, however, it does not appear to be
severely compromised (Figure 3F). In conse-
quence, we cannot formally exclude that the
ASP3-dependent defect in host plasma mem-
brane lysis is caused by partially impaired PLP1
activity.
ASP3 indirectly impacts on the
post-exocytosis processing of
microneme proteins
Following secretion, MICs are proteolytically
trimmed, the role of which is less well under-
stood. Although depletion of ASP3 does not impact on microneme secretion (Figure 1J), the post-
exocytosis processing pattern of some MICs is nonetheless altered with an accumulation of unpro-
cessed forms (Figure 3H). In WT parasites, M2AP undergoes multiple cleavages post-exocytosis
generating four fragments, MIC2 (100 kDa) is processed at the N-terminus, which removes a 5 kDa
fragment and MIC4 (72 kDa) is sequentially cleaved N-terminally to generate 70 kDa and 50 kDa
products (Lagal et al., 2010). In ASP3 depleted parasites, M2AP secreted products, the 95 kDa
secreted form of MIC2 and the 50 kDa form of MIC4 are absent (Figure 3H–I). In contrast, the rhom-
boid–dependent cleavage within the transmembrane domain of MIC2 and AMA1 occurs normally
(Figure 1J and Figure 3H). Consistent with these observations, the rhomboid proteases ROM4 and
ROM5 responsible for AMA1 and MIC2 cleavage (Rugarabamu et al., 2015; Shen et al., 2014b) are
known to be constitutively active, whereas SUB1 involved in the post-exocytosis processing of MIC2,
MIC4 and M2AP needs to be activated by a maturation process implicating the removal of the SUB1
pro-domain (Lagal et al., 2010; Saouros et al., 2012). Output data from the TAILS analysis revealed
abundant enrichment for SUB1 peptides, indicative of a plausible ASP3 substrate (Table 1). IFA anal-
yses performed with either cross-reacting anti-PfSUB1 antibodies or on SUB1ty tagged parasites,
revealed no alteration in the trafficking or secretion of SUB1 in the absence of ASP3 (Figure 3J). In
contrast, the post-exocytosis processing profile of SUB1 was clearly affected (Figure 3K). These
results suggest a direct or indirect role for ASP3 in SUB1 maturation leading to its activation on the
parasite surface.
ASP3 is necessary for the processing of the ROPs and RONs
ROPs and RONs represented a significant fraction of hits in the TAILS data that prompted us to
investigate whether ASP3 could act as protein maturase for the ROPs and RONs. The lysates of
ASP3ty-iKD +/ ATc were analyzed by WB and revealed that RONs and ROPs precursors accumu-
lated as non-processed forms in parasites treated for 24 and 48 hr with ATc (Figure 4A–D). The tar-
geting of the ROPs/RONs to the rhoptries is not affected by the block of ASP3-dependent
processing, (Figure 4F and Figure 4—figure supplement 1A–B), corroborating previous observa-
tions on some of the ROPs (Bradley et al., 2002; Miller et al., 2003; Turetzky et al., 2010). The
processing phenotype is complemented by the second copy of wild type ASP3 but not the catalyti-
cally dead mutant asp3-D299A, as shown for ROP2-4 (Figure 4E). Given the severe defect in inva-
sion caused by ASP3 depletion, we assessed whether unprocessed RONs would be affected in their
assembly as a complex. Co-immunoprecipitation experiments confirmed that the RON2 and RON4
Video 3. ASP3 depleted parasites display impaired
egress. Motile ASP3 depleted parasites were trapped
either in the host cell membrane and/or the PVM. The
parasites are very motile within and attempt to
mechanically rupture the membranes with most
eventually escaping.
DOI: https://doi.org/10.7554/eLife.27480.012
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Figure 2. Global analysis of MS data and peptide ratios. (A) All measured spectra (65’900) minus those with low quality attributes leave 32’594 high
quality spectra (9169 peptide groups) for the analysis. The graphical representation depicts proportions of N-terminal peptides in the pre-TAILS and
TAILS datasets (blue pie charts) and corresponding N-acetyl modifications (ochre pie charts). N-termini in the TAILS fraction are enriched by >10 fold
(69% vs 6%) over internal peptides (generated by trypsin cleavage). (B) Graphical representation of the 1529 proteins in the combined datasets. Of
those 642 and 293 are unique to the pre-TAILS or the TAILS fractions, respectively. (C) Graphical depiction of data generated by calculating +ATc/-ATc
peptide ratios revealing ASP3-dependent processing (for details see also Table supplement 1-4). Threshold ratios (r) are indicated in the Venn diagram.
Figure 2 continued on next page
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were still associated (Figure 4G), despite the accumulation of unprocessed forms as reported
(Figure 4C–D).
Like micronemes, the rhoptries contain several proteases that might participate in protein matura-
tion events. Toxolysin-1 (TLN1) is a metalloprotease, localized both to the bulb and the neck of the
rhoptries, which is known to undergo a C-terminal cleavage in addition to the removal of its pro-
domain mediated by two distinct, uncharacterized maturases (Figure 4H) (Hajagos et al., 2012).
Consistent with this previous observation, ASP3 depletion prevents the pro-domain processing
whereas the C-terminal cleavage remains unaffected (Figure 4I). Subtilisin 2 (SUB2) is a rhoptry pro-
tease previously suspected to participate in the removal of the pro-domains of the rhoptry proteins
at a consensus SjXE site (Figure 4—figure supplements 2 and 3) (Miller et al., 2003). As observed
for SUB1, we envisioned that ASP3 could be implicated in the maturation and activation of SUB2
and thus indirectly affected the cleavage of ROPs and RONs. However, endogenous tagging of
SUB2 in the background of an inducible ASP3 knockdown strain (SUB2ty/ASP3-iKD) did not reveal
any evident defect in the protease maturation (Figure 4—figure supplement 4A). To more firmly
confirm this result, the disruption of SUB2 gene was performed with the assistance of CRISPR/Cas9
genome editing and revealed that ROPs and RONs are still processed normally in SUB2-KO para-
sites (Figure 4—figure supplement 4B–E). This excludes the presumed role of SUB2 as a maturase
for the ROPs, and suggests instead that ASP3 could be directly responsible for the processing of
ROPs and RONs.
Novel rhoptry proteins identified as ASP3 substrates by the TAILS
analysis
To further validate the TAILS analysis, we explored 8 hypothetical proteins (named TAILS1-8) from
the TAILS dataset (relaxed stringency, with either >2 and <0.5 ratios), selected based on their
expression profile, fitness score (Sidik et al., 2016) and conservation (Table 1, Supplementary files
1–3 and Figure 5—figure supplement 1). Epitope-tagging of the candidates at the endogenous
locus in ASP3myc-iKD revealed that 5 out of the 8 gene products localized to the rhoptries, overlap-
ping with ARO, a known marker of the rhoptries (Figure 5B,D,F,H,J). This is consistent with the cell
cycle dependent expression profile of their transcripts (Behnke et al., 2010) (Figure 5—figure sup-
plement 1). While TAILS1 (TGME49_202870) has a nuclear localization, TAILS4 (TGME49_239050)
appears to be cytosolic (data not shown). Despite having a typical rhoptry expression profile TAILS2
(TGME49_225860) could not be localized. TAILS3 (TGME49_230350), referred to as a hypothetical
protein, corresponds to RON11, a polytopic protein containing a calcium binding EF-hand at its C--
terminus recently characterized as a dispensable rhoptry neck protein (Wang et al., 2016). Western
blot analysis of these tagged TAILS proteins in ASP3myc-iKD +/ ATc revealed defects in processing
of all the rhoptry localized proteins and hence confirming them as either direct or indirect ASP3 sub-
strates (Figure 5C,E,G,I,K). Intriguingly, in presence of ATc, the unprocessed forms of TAILS3 and
TAILS8 (TGME49_321650) exhibit an altered distribution within the organelle (Figure 5L,M), but not
the TAILS 5, TAILS6 and TAILS7 (Figure 5—figure supplement 2). Overall, these results led to the
identification of 5 novel rhoptry proteins, validating further the robustness of the TAILS analysis as a
powerful technique for protease substrates identification.
Figure 2 continued
Lists of proven or predicted secreted proteins represented by peptides with ratios indicated in the circles corresponding to each area in the diagram
are boxed. Inset pie charts indicate the proportions of secreted (light sector) vs. cytosolic proteins (dark sector). Gene models for hypothetical proteins
are indicated by the ToxoDB 6 digit designator (prefix TGGT1_).
DOI: https://doi.org/10.7554/eLife.27480.013
The following figure supplement is available for figure 2:
Figure supplement 1. Schematic of the TAILS assay.
DOI: https://doi.org/10.7554/eLife.27480.014
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Table 1. List of peptides detected in the combined TAILS datasets with +ATc/-ATc peptide ratios < 0.22 (green columns) and >2
(red columns).
ToxoDB gene name
Position in master
protein Annotated peptide sequence
Atc+/Atc-
Ratio  0.22
(log2) Atc+/Atc-
Ratio   2.18
SUB1 TGGT1_204050 [45-59] [E].YQNPTSTYNLIKEIR.[K] 0.039  4.69
SUB1 TGGT1_204050 [43-59] [H].GEYQNPTSTYNLIKEIR.[K] 0.194  2.36
PLP1 TGGT1_204130 [200-
220]
[T].APDDDFDFLFEDDTPKKPKSR.[V] 0.156  2.68
MIC11 TGGT1_204530 [58-68] [T].EDDKSAASIVR.[G] 0.045  4.48
MIC4 TGGT1_208030 [45-77] [D].ITPAGDDVSANVTSSEPAKLDLSCVHSDNKGSR.[A] 0.186  2.42
MIC4 TGGT1_208030 [58-77] [T].SSEPAKLDLSCVHSDNKGSR.[A] 0.19  2.4
Hypothetical TGGT1_212210 [196-
220]
[L].FKTGSSENNEVLPSFQDAEKAAPVR.[R] 0.168  2.58
MIC6 TGGT1_218520 [95-
123]
[S].ETPAACSSNPCGPEAAGTCKETNSGYICR.[C] 0.089  3.5
Hypothetical TGGT1_221180 [471-
501]
[A].ADGDSGAGTGSPGETSSKQDSGGVGTKVDAR.[V] 0.164  2.61
Hypothetical (TAILS5) TGGT1_258360 [83-
99]
[Q].SASEADEEEESGGSSKR.[S] 0.163  2.62
Hypothetical TGGT1_261740 [52-79] [R].ASHSSSKGEGGDEEKHKDKSPEEGAGDR.[D] 0.205  2.29
ROP16 TGGT1_262730 [29-40] [F].EEAQKASEAAKR.[Q] 0.159  2.65
Hypothetical (TAILS6) TGGT1_273860 [145-
166]
[K].QTTKKDEDEDGSEDSEDDEAER.[A] 0.049  4.34
Hypothetical (TAILS6) TGGT1_273860 [147-
166]
[T].TKKDEDEDGSEDSEDDEAER.[A] 0.079  3.66
Hypothetical (TAILS6) TGGT1_273860 [143-
166]
[S].AKQTTKKDEDEDGSEDSEDDEAER.[A] 0.097  3.37
Hypothetical (TAILS7) TGGT1_279420 [184-
205]
[F].SELKSTKSSTAPSDSVKAAATR.[L] 0.22  2.18
Putative HSP75 TGGT1_292920 [825-
849]
[A].EDDKAQPDSSSAQTDSTAGSEVEPR.[K] 0.141  2.82
ROP13 TGGT1_312270 [67-90] [E].GTNETNPPTSRPPGWKYEGSDLHR.[R] 0.219  2.19
Hypothetical TGGT1_315270 [25-45] [T].LLPSAPKPVDEAALAAAEKER.[E] 0.19  2.4
MIC3 TGGT1_319560 [57-86] [F].AVTETHSSVQSPSKQETQLCAISSEGKPCR.[N] 0.074  3.76
MIC3 TGGT1_319560 [67-86] [Q].SPSKQETQLCAISSEGKPCR.[N] 0.079  3.65
MIC3 TGGT1_319560 [69-86] [P].SKQETQLCAISSEGKPCR.[N] 0.192  2.38
Hypothetical (TAILS8) TGGT1_321650 [257-
268]
[F].AEHKSGGEKASR.[E] 0.156  2.68
ToxoDB Gene Name Positions in Master
Proteins
Annotated Peptide Sequence Atc+/Atc-
Ratio  2
(log2) Atc+/Atc- Ratio  1
MIC2 TGGT1_201780 [27-36] [G].GGWSIVDALR.[K] 3.317 1.73
SUB1 TGGT1_204050 [212-
225]
[V].NTSSKGSNDPLLDR.[L] 3.267 1.71
SUB1 TGGT1_204050 [214-
225]
[T].SSKGSNDPLLDR.[L] 3.837 1.94
MIC11 TGGT1_204050 [40-59] [L].SHHGEYQNPTSTYNLIKEIR.[K] 4.195 2.07
MIC11 TGGT1_204530 [23-32] [G].VSEGVVVPVR.[F] 2.175 1.12
MIC11 TGGT1_204530 [25-32] [S].EGVVVPVR.[F] 3.548 1.83
ROP18 TGGT1_205250 [50-72] [T].LGPSKLDSKPTSLDSQQHVADKR.[W] 4.985 2.32
Hypothetical TGGT1_210370 [65-89] [N].NPPPLEGASVSPENATDPPETGGSR.[R] 2.824 1.5
Methionine
aminopeptidase
TGGT1_211330 [338-
359]
[C].SSPDVSSDNASSSTDLSFPVLR.[R] 2.033 1.02
Table 1 continued on next page
Dogga et al. eLife 2017;6:e27480. DOI: https://doi.org/10.7554/eLife.27480 10 of 35
Research article Microbiology and Infectious Disease
Table 1 continued
ToxoDB gene name
Position in master
protein Annotated peptide sequence
Atc+/Atc-
Ratio  0.22
(log2) Atc+/Atc-
Ratio   2.18
Hypothetical (TAILS3) TGGT1_230350 [134-
141]
[K].LDNPELSR.[Q] 3.549 1.83
IMC1 TGGT1_231640 [1-20] [-].MFKDCADPCSDCCQPAEQQR.[G] 2.028 1.02
IMC1 TGGT1_233820 [1-27] [-].MKPPSGLSGASAQGVGAEETSVSLLAR.[L] 2.028 1.02
IMC1 TGGT1_235620 [13-49] [M].
VMPASQGAPHGAIAAESQEKTNSCVSQECPASSETAR.
[Q]
2.466 1.3
Peptidase M16 TGGT1_236210 [36-53] [G].FFSAAPAAATAGVSPLAR.[S] 2.005 1
Hypothetical (TAILS4) TGGT1_239050 [432-
438]
[P].LSPPDSR.[G] 5.526 2.47
ROP9 TGGT1_243730 [59-71] [P].QGSPPASQKEAIR.[D] 2.275 1.19
Hypothetical TGGT1_247520 [44-58] [Q].NPAGGKGGSGPHGGR.[R] 2.431 1.28
Hypothetical TGGT1_247520 [36-58] [A].SDQKQGSQNPAGGKGGSGPHGGR.[R] 6.971 2.8
Hypothetical TGGT1_247960 [43-52] [L].LPGDPVLFPR.[S] 9.446 3.24
ROP17 TGGT1_258580 [26-42] [R].SPTSNDVFGELVASAER.[A] 12.98 3.7
ROP6 TGGT1_258660 [65-79] [K].GSDFGEVKLGSAGQR.[Q] 6.897 2.79
Hypothetical TGGT1_261740 [56-79] [S].SSKGEGGDEEKHKDKSPEEGAGDR.[D] 3.973 1.99
Hypothetical TGGT1_261740 [54-79] [S].HSSSKGEGGDEEKHKDKSPEEGAGDR.[D] 5.053 2.34
Hypothetical TGGT1_261740 [56-79] [S].SSKGEGGDEEKHKDKSPEEGAGDR.[D] 11.39 3.51
ROP16 TGGT1_262730 [27-40] [M].SFEEAQKASEAAKR.[Q] 6.953 2.8
Hypothetical TGGT1_268835 [152-
160]
[R].DSWMSLAPF.[V] 2.14 1.1
SRS30C TGGT1_273120 [53-79] [A].AKAQGGETPPSDPTCVVEGAVTKCTCR.[N] 3.009 1.59
Hypothetical TGGT1_276190 [1-31] [-].MSPADPEAGSLQSSAPPLASAGKSAGAGAPR.[A] 2.081 1.06
ROP40 TGGT1_291960 [53-67] [A].TDSDSEPEGKGGYQR.[L] 6.511 2.7
ROP40 TGGT1_291960 [55-67] [D].SDSEPEGKGGYQR.[L] 7.127 2.83
Hypothetical TGGT1_295360 [1-29] [-].MEQQQDELKHSWGANELPAGQQGSPLAER.[Q] 2.309 1.21
RON6 TGGT1_297960A [50-
56]
[L].LPAGQDR.[S] 3.172 1.67
ROP1 TGGT1_309590 [274-
296]
[L].LEPTEEQQEGPQEPLPPPPPPTR.[G] 2.111 1.08
ROP1 TGGT1_309590 [58-76] [G].VPAYPSYAQVSLSSNGEPR.[H] 4.051 2.02
ROP1 TGGT1_309590 [87-
115]
[M].SVKPHANADDFASDDNYEPLPSFVEAPVR.[G] 4.094 2.03
ROP1 TGGT1_309590 [103-
115]
[N].YEPLPSFVEAPVR.[G] 10.23 3.36
RON1 TGGT1_310010 [66-82] [R].AAANGSEGGVAQSEQER.[A] 3.193 1.67
ROP10 TGGT1_315490 [35-48] [R].ESPQWDSLLPLQDR.[R] 16.32 4.03
MIC3 TGGT1_319560 [60-86] [T].ETHSSVQSPSKQETQLCAISSEGKPCR.[N] 4.882 2.29
MIC3 TGGT1_319560 [56-86] [S].FAVTETHSSVQSPSKQETQLCAISSEGKPCR.[N] 9.061 3.18
MIC3 TGGT1_319560 [64-86] [S].SVQSPSKQETQLCAISSEGKPCR.[N] 11.35 3.5
MIC3 TGGT1_319560 [52-86] [S].LAPSFAVTETHSSVQSPSKQETQLCAISSEGKPCR.
[N]
34.74 5.12
DOI: https://doi.org/10.7554/eLife.27480.015
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Figure 3. ASP3 is a maturase for microneme proteins and impacts microneme processing post-exocytosis via SUB1. (A) Schematic representation of
MICs and their processing pre-exocytosis (red) and post-exocytosis by ROM4/5 (light blue). (B) Immunoblots assessing the processing of the microneme
proteins M2AP, MIC3, MIC6, AMA1 upon ASP3 knockdown. Catalase was used as loading control. (C) ASP3ty but not asp3ty-D299A can rescue the
processing of MIC6 in absence of ASP3myc. (D), (E), (F) Immunoblots assessing the processing of the microneme proteins MIC5, TLN4 and PLP1 upon
ASP3 knockdown. MIC5 was Ty-tagged at the endogenous locus in ASP3-iKD and transient plasmid transfection of epitope tagged TLN4 was used. (G)
Figure 3 continued on next page
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The ethylamine scaffold based compound 49c recapitulates ASP3
depletion phenotypes
Aspartyl proteases qualify as attractive targets for chemotherapy against pathogens and have been
the focus of intense research toward the identification of antimalarial drugs. Interestingly, 49c
belongs to a series of antimalarials based on a hydroxyethylamine scaffold, and designed to inhibit
the malaria Plasmepsin II (Boss et al., 2003; Ciana et al., 2013) (Figure 6A). 49c exhibits a subnano-
molar IC50 against P. falciparum and acts on the late erythrocytic stages by blocking egress and
invasion, potentially targeting the two late schizont aspartyl proteases, PMIX and PMX, that cluster
phylogenetically with ASP3 (Figure 1—figure supplement 1). Given the significant sequence conser-
vation between the members of this cluster (Figure 1—figure supplement 2B), we hypothesized
that 49c could target ASP3 and impact on T. gondii invasion and egress. Concordantly, 49c inter-
feres with the lytic cycle of T. gondii tachyzoites, with an IC50 of ~676 nM (Figure 6B). A deeper
analysis confirmed that 49c blocks invasion, egress and rhoptry discharge without impacting on glid-
ing motility, intracellular growth and microneme secretion (Figure 6C–G and Figure 6—figure sup-
plement 1A–B). Moreover, 49c accurately recapitulates ASP3 depletion by inhibiting MICs, ROPs
and RONs pre-exocytosis as well as some post-exocytosis processing events of MICs, without affect-
ing their trafficking to the respective secretory organelles (Figure 6E,F,H and Figure 6—figure sup-
plement 1C–D). In contrast, 49b, another hydroxyethylamine scaffold derivative having poor efficacy
against Plasmodium (Ciana et al., 2013) showed concordant low inhibitory activity against tachy-
zoites (IC50 >10 mM) (Figure 6A,B,H). We took advantage of the inhibitory effect of 49c on ASP3 to
narrow down the time of action of ASP3 during biogenesis and maturation of the secretory organ-
elles. A minimal impact on invasion and egress was measured when the parasites were treated with
49c either in extracellular condition or less than 3 hr prior to natural egress or calcium ionophore
stimulated egress (Figure 6I–K). Comparatively, 49c mediated defect in invasion or induced egress
was highest when the parasites were pre-treated for 42 to 48 hr (Figure 6I–K). Moreover, washing
the compound just 6 hr or even only 3 hr prior to inducing the egress failed to rescue the pheno-
type, resulting in no significant increase in the number of lysed vacuoles due to egress (Figure 6J–
K). This is consistent with a block in the maturation of the MICs, ROPs and RONs that are produced
and processed during the 2–3 hr period dedicated to the biogenesis of the secretory organelles
(Nishi et al., 2008). Taken together, the time frame of parasite sensitivity to 49c reflects the time
necessary for the maturation and trafficking of the MICs/RONs/ROPs prior to reaching their respec-
tive organelles.
In T. gondii tachyzoites, the other expressed ASP1, ASP2 and ASP5, are dispensable. Importantly,
ASP5 plays a key role in the formation of the intravacuolar membranous nanotubular network (MNN)
(Hammoudi et al., 2015; Coffey et al., 2015). However, ASP3 depleted parasites and 49c treated
parasites are not affected in MNN formation (Figure 6—figure supplement 2A). Moreover 49c has
no impact on the maturation of ASP5 or on the processing and export of GRA16, an ASP5 substrate,
inferring that 49c does not inhibit ASP5 (Figure 6—figure supplement 2B–D).
In vitro cleavage activity of ASP3 and inhibition by 49c
To formally demonstrate that ASP3 acts as secretory protein maturase, we immunoprecipitated
ASP3ty from extracellular parasites under native conditions and assessed its proteolytic activity
Figure 3 continued
IFAs evaluating the localization of microneme proteins upon ASP3 depletion – M2AP, MIC6 and MIC3, co-localized with either MIC2 or AMA1. White
arrowhead points to the pro form of M2AP. (H) Immunoblot analyses of ESA from ASP3ty-iKD parasites, +/ ATc, after 2% EtOH stimulation show
impaired post-exocytosis cleavage of MIC2, M2AP and MIC4. (I) Schematic representation of microneme proteins and their putative processing post-
exocytosis by SUB1. (J) Endogenously tagged SUB1 was localized in the microneme independently of ASP3. (K) Depletion of ASP3 showed impaired
processing of SUB1in ESA analyses. TgSUB1 was detected using an antibody raised against PfSUB1. Black arrowheads represent pro and mature forms
of the proteins.
DOI: https://doi.org/10.7554/eLife.27480.016
The following figure supplement is available for figure 3:
Figure supplement 1. Effect of ASP3 depletion on MICs.
DOI: https://doi.org/10.7554/eLife.27480.017
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Figure 4. ASP3 is involved in the processing of rhoptry proteins. (A), (B) Immunoblots evaluating the processing of the rhoptry bulb proteins ROP1,
ROP2-4, ROP7, ROP13, and ROP18 upon ASP3 knockdown. ROP18 was Ty-tagged at endogenous locus in ASP3-iKD. Catalase was used as a loading
control. Arrowheads represent pro and mature forms of the proteins. (C), (D) Immunoblots evaluating the processing of the rhoptry neck proteins
RON2, RON4, RON5 and RON9 upon ASP3 knockdown. RON2 and RON5 were Ty-tagged at the endogenous locus in ASP3-iKD. (E) ASP3ty but not
asp3ty-D299A can rescue the processing of ROP2-4 in absence of ASP3myc. (F) IFAs evaluating localization of ROP1, ROP18, RON4, and RON9 upon
ASP3 knockdown. No alteration was observed in absence of ASP3. (G) ASP3 depletion did not impact on the formation of the RON4-RON2 complex as
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(Figure 7—figure supplement 1A). The cleavage site of MIC6 was previously mapped after Ser94
(VQLS|ETPA) (Meissner et al., 2002), and this position was also confirmed by the TAILS analysis
(Table 1 and Supplementary files 1 and 2). Firstly, a bacterial recombinant fragment of MIC6
encompassing the first three EGF domains (GST-MIC6) including the VQLS|ETPA cleavage site was
used as substrate. GST-MIC6 was cleaved efficiently by pulled-down ASP3ty while no processing
was detectable using the catalytically dead asp3ty-D299A (Figure 7A). These results were confirmed
with a fluorogenic peptide, 10 amino acids long, comprising the predicted cleavage site (Figure 7C–
D). Again no processing was detectable using asp3ty-D299A, confirming that the observed activity
is specific to ASP3ty (Figure 7D).
To confirm that 49c acts as selective inhibitor for ASP3, this compound as well as 49b were tested
on the MIC6 peptide and GST-MIC6 in in vitro cleavage assays. 49c blocked the cleavage of GST-
MIC6 cleavage at 1 mM and of MIC6 peptide cleavage at a concentration of 100 nM, whereas pep-
statin A, a potent and reversible inhibitor of aspartic proteases of microbial origin, had no inhibitory
effect on ASP3 activity even at 10 mM (Figure 7B,D). To further support the broadness of ASP3 sub-
strate specificity, additional fluorogenic peptides were tested (Figure 7E–F). ROP1 peptide was cho-
sen based on its known cleavage site (Bradley and Boothroyd, 1999; Soldati et al., 1998) whereas
MIC3 and ROP13 peptides were based on the deduced cleavage site from the TAILS analysis. SUB1
peptide was chosen based on the putative SjXE cleavage site (Figure 7E–F). In the absence of
experimental data, a RON4 peptide was designed based on in silico prediction of a putative cleav-
age site and deduced cleavage site from TAILS data (Figure 7—figure supplement 1B and
Supplementary file 2). The results confirmed that ASP3 acts as a maturase for MICs and ROPs
whereas the data on RONs remain inconclusive given the uncertainty about the cleavage site. 49c
consistently blocks ASP3 activity on MIC and ROP substrates, compellingly supporting that its inhibi-
tory effect on the parasite lytic cycle is mediated through ASP3 inhibition.
Discussion
The large repertoire of regulated secretory proteins stored in micronemes critically participate in
invasion and egress while rhoptry proteins are dedicated to invasion, PVM formation and subversion
of host cellular functions. MICs are processed prior to exocytosis by uncharacterized proteases and
post-exocytosis by subtilisin and rhomboid-like proteases. Even less in known about the processing
of RONs and ROPs and the protease(s) implicated. Earlier studies have postulated the contribution
of CPL and SUB2 towards the processing of MICs and ROPs respectively (Miller et al., 2003;
Parussini et al., 2010), however, in both cases, either limited or no direct evidence were supporting
the claims.
We have demonstrated here that ASP3 is a resident aspartyl protease of the ELC, critical for
tachyzoites invasion and egress but not implicated in parasite replication, gliding motility and host
cell attachment. To explain ASP3 depletion phenotypes at the molecular level, we applied for the
first time the power of TAILS analysis to generate in-depth characterization of ASP3 dependent pro-
tein N-termini in T. gondii. TAILS pipeline is based on negative selection, where native as well as
proteolytically generated protein N-termini are identified and quantified. A comparative analysis
Figure 4 continued
demonstrated by co-immunoprecipitation of RON2 with RON4 antibodies. (H) Schematic for the processing events and products of TLN1. (I)
Immunoblot evaluating TLN1 showed that ASP3 depletion abolished the pro-domain processing of TLN1.
DOI: https://doi.org/10.7554/eLife.27480.018
The following figure supplements are available for figure 4:
Figure supplement 1. Effect of ASP3 depletion on rhoptry proteins.
DOI: https://doi.org/10.7554/eLife.27480.019
Figure supplement 2. SjXE motifs in ROPs.
DOI: https://doi.org/10.7554/eLife.27480.020
Figure supplement 3. SjXE motifs in RONs.
DOI: https://doi.org/10.7554/eLife.27480.021
Figure supplement 4. SUB2 has no impact on the processing of ROPs/RONs/MICs.
DOI: https://doi.org/10.7554/eLife.27480.022
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Figure 5.  TAILS analysis identified new rhoptry proteins as ASP3 substrates. 
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Figure 5. TAILS analysis identified new rhoptry proteins as ASP3 substrates. (A) Schematic representation of the different candidate identified during
the TAILS analysis. SP – signal peptide, TM – transmembrane, SAP - SAF-A/B, Acinus and PIAS domain, TSP1 - thrombospondin-1, S-TKc – Serine-
Threonine kinase catalytic domain. (B), (D), (F), (H), (J) TAILS 3, 5, 6 7 and 8 were localized to the rhoptries and (C), (E), (G), (I) (K) showed impaired
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between WT and ASP3-depleted parasites identified protease cleavage sites dependent on ASP3.
The obtained TAILS data document many proteolytic processing events accurately but as a method
also highlight secondary effects of ASP3 knockdown with considerable sensitivity. The most frequent
case is detection of peptides representing degradation products that increase in +ATc conditions
presumably due to accumulation of unprocessed precursors, and in some cases temporally and spa-
tially incorrect trafficking (Prudova et al., 2016).
The criteria applied for the identification of ASP3-dependent processing events are +ATc/-ATc
ratios of <0.22 (0.5) for N-terminal peptides in conjunction with the detection of additional peptides
representing immature or degraded products with ratios >2. The over-representation of MICs, ROPs
and RONs as ASP3 candidate substrates was compelling. Taken together, the results of the TAILS
analysis to detect ASP3-dependent substrates show that interpretation of peptide ratio profiles can
be relatively straightforward in some cases (e.g. MIC3, 11), but requires more in-depth analysis of
the MS data in others (e.g. MIC6, TGGT1_273860 – TAILS3) (Appendix 1). Even though TAILS can
never be comprehensive in terms of defining protease-specific substrates in knockdown parasites, a
detailed analysis of the data was instrumental to inform about new targets for experimental testing.
The TAILS analysis confirms the previously reported cleavage site of MIC6 (VQLS|ETPA), ROP1
(SFVE|APVR) and ROP13 (SFTE|GTNE). Similarly, several peptides corresponding to cleavage sites
around the putative rhoptry cleavages site, SjXE, were detected, confirming the reliability of the
experimental procedure and highlighting the strength of TAILS N-terminomics. The purified ASP3
was used to firmly prove that MIC6, MIC3, ROP1 and ROP13 are ASP3 substrates based on enzy-
matic cleavage assay on the corresponding fluorogenic peptides (Figure 7D–F). However, the data
did not reveal an obvious consensus sequence motif for ASP3-specific cleavage sites. It is likely that
substrate recognition and cleavage are governed by both secondary structure features and interac-
tions between the amino acids surrounding the substrate cleavage site and the protease. It should
also be noted that the many cleavage events and enriched peptides could possibly be due to sec-
ondary effects caused by altered abundance or activation of other proteases upon ASP3 depletion.
The combination of in vivo and in vitro data demonstrates the role of ASP3 in the pre-exocytosis
processing of apical organellar proteins – MICs, ROPs. While no direct evidence was obtained to
demonstrate that ASP3 processes the RONs, it is likely to be the case.
In parallel, we also obtained experimental evidence for ASP3-dependent processing in the
absence of TAILS supporting data. Importantly, it was possible to show that the pattern of SUB1
processing is altered in absence of ASP3, which hampers its activation and thus explains the indirect
impact of ASP3 depletion on the post-exocytosis processing of MIC2, M2AP and MIC4 (Figure 3G–
J).
Depletion of ASP3 causes a severe block both in invasion and egress that could be attributed to
a defect in rhoptry discharge and in host plasma membrane lysis, respectively. As reported earlier,
the cleavage per se is not essential for trafficking of organellar proteins to their respective organ-
elles. In consequence, the phenotypic links between an absence of proteolytic processing of ROP/
RON/MIC proteins and the observed phenotypes are not obvious. Both microneme exocytosis and
rhoptry discharge occur at the apex of the parasite during invasion. While microneme secretion is
driven by changes in cytoplasmic calcium concentration and by phosphatidic acid production
(Bullen et al., 2016) that can be triggered by various chemicals such as ethanol, the trigger for rhop-
try secretion is still elusive (Lourido and Moreno, 2015; Sharma and Chitnis, 2013). At the time of
invasion, the parasite’s apical tip comes in close contact with the host cell membrane leading to
rhoptry discharge. The secreted rhoptry material fuses with the invaginating host cell membrane and
Figure 5 continued
processing upon ASP3 depletion. Arrowheads represent pro and mature forms of the proteins. MIC6 was used as control. (L, M) Altered localization of
TAILS3 and TAILS8 in the rhoptries upon ASP3 depletion.
DOI: https://doi.org/10.7554/eLife.27480.023
The following figure supplements are available for figure 5:
Figure supplement 1. Expression profile of TAILS candidates.
DOI: https://doi.org/10.7554/eLife.27480.024
Figure supplement 2. Effect of ASP3 knockdown on the localization of the TAILS candidates.
DOI: https://doi.org/10.7554/eLife.27480.025
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Figure 6. 49c recapitulates the phenotype of ASP3 depletion in T. gondii. (A) Chemical structure of compounds 49b and 49c. (B) IC50 on T. gondii RH-
pTub-CBG99-luciferase parasites of 49b (13.8 mM), 49c (676 nM) and Pyrimethamine (295 nM), used here as a positive control. (C) 49c treatment
impaired RH parasites invasion and (D) egress. Data are presented as mean ±standard deviation (SD) from 3 independent experiments. (E, F) Parasites,
treated for 36 hr with DMSO or 49c, showed normal secretion of microneme proteins (MIC2, M2AP, MIC4), but altered processing in this fraction (MIC2,
M2AP, MIC4). Arrowheads show full length and secreted fragments. Catalase was used as cytosolic control and GRA1 for constitutive secretion. (G) 49c
treated during 48 hr of Dku80 parasites displayed a complete absence of rhoptry content secretion as assessed by probing against the rhoptry protein
ROP1. (H) Processing of RON4, ROP18 and MIC6 was affected by 48 hr of 49c treatment while DMSO treated samples were not affected. AMA1 serves
a control for an unprocessed microneme and Catalase as loading control. ROP18 was Ty-tagged at endogenous locus. Pepstatin was used as a
negative control. (I) Invasion was blocked by 49c when parasites were treated for 6 hr or more prior to egress, but not less than 3 hr or when
Figure 6 continued on next page
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forms the PVM. To date, only two proteins have been associated to rhoptry discharge – ARO, which
is implicated in the apical positioning of the rhoptries (Mueller et al., 2013) whereas the role of type
I transmembrane microneme protein MIC8 is not understood (Kessler et al., 2008). Here we show
that the rhoptries are apically positioned and MIC8 is not affected by ASP3 depletion, which leaves
open the identification of the ASP3 substrate implicated in rhoptry discharge. In contrast, PLP1 is an
obvious candidate to explain the defect in egress observed in ASP3 depleted parasites. PLP1 was
identified in the TAILS analysis and WB performed in absence of ASP3 indicates slight alternation of
the processing pattern that might result in a partial dysfunction of the perforin activity (Roiko and
Carruthers, 2013).
The TAILS dataset identified several hypothetical proteins and 5 out of the 8 candidates analyzed
further, were confirmed as bona fide rhoptry proteins and ASP3 substrates. Functional characteriza-
tion of these and other TAILS candidates should help identifying the factor critical for the initial step
of invasion and implicated in rhoptry discharge.
Invasion and egress are key events for survival and dissemination of the Apicomplexa and an
aspartic protease essential for these two steps constitutes an attractive target for drug intervention.
Antimalarials primarily target apicoplast or food vacuole that are hosting metabolic pathways and
ensuring parasite growth. The Plasmodium aspartic proteases in particular have been explored for
specific inhibitors, with a main focus on the food vacuole Plasmepsins implicated in haemoglobin
degradation (Figure 1—figure supplement 1). However, a considerable redundancy among the pro-
teases involved render them sub-optimal targets. We report here on an aspartyl protease inhibitor
that acts at subnanomolar IC50 on P. falciparum and presumably targets the Plasmepsins IX and X
that belong to the same phylogenetic cluster as ASP3 (Figure 1—figure supplement 1). 49c is a
hydroxyethylamine scaffold based compound that kills T. gondii with an IC50 of 676 nM by blocking
invasion (rhoptry discharge) and egress, without impacting on gliding motility, intracellular growth or
microneme secretion. 49c recapitulates the ASP3 depletion phenotypes and inhibits the processing
of ASP3 substrates. 49c also compellingly blocked ASP3 mediated cleavage of substrates (MIC6,
ROP1, ROP13, SUB1, MIC3) in vitro, thus confirming that it targets ASP3 with high specificity.
In conclusion, we characterized a T. gondii aspartyl protease, ASP3, essential for parasite egress
and discharge of rhoptry content, thereby, invasion. TAILS analysis and subsequent validation led to
define the repertoire of ASP3 substrates. The peptidomimetic inhibitor 49c validates the druggability
of ASP3 to interfere with two key steps in the lytic cycle of this apicomplexan parasite.
Materials and methods
Toxoplasma, host cell and bacteria culture
T. gondii tachyzoites, parental and modified strains, were grown in confluent monolayers of human
foreskin fibroblasts (HFFs) in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco) supplemented
Figure 6 continued
extracellular. (J) Parasites were blocked in egress when treated with 49c at least 3 hr before induced egress, but not later. (K) Schematic showing the
various treatments for the induced egress assay in J.
DOI: https://doi.org/10.7554/eLife.27480.026
The following source data and figure supplements are available for figure 6:
Source data 1. Source data of the triplicate experiments done on RHDku80 parasites (DMSO or 49c treated) Intracellular growth assay (Figure 6—fig-
ure supplement 1A), Invasion assay (C), Egress assay (D), Invasion assay with washes (I) and Egress assay with washed (J).
DOI: https://doi.org/10.7554/eLife.27480.029
Source data 2. Source data of the in vitro measurement of IC50 done on luciferase expressing T. gondii tachyzoites (Figure 6B).
DOI: https://doi.org/10.7554/eLife.27480.030
Figure supplement 1. 49c has no impact on parasite intracellular replication, gliding motility, and on the localization of rhoptry and microneme
proteins.
DOI: https://doi.org/10.7554/eLife.27480.027
Figure supplement 2. 49c has no impact on ASP5 maturation, intravacuolar membranous nanotubular network (MNN) formation or on the maturation
and export of ASP5 substrate, GRA16.
DOI: https://doi.org/10.7554/eLife.27480.028
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Figure 7. In vitro cleavage of ASP3 substrates. (A) Recombinant GST-MIC6 was processed by ASP3ty but not by asp3ty-D299A. Pepstatin A was used as
negative control. (B) 49c but not 49b prevented GST-MIC6 processing by ASP3ty. ASP3 WT and asp3ty-D299A mutant were immunoprecipitated from
the parasite. (C) Schematic representation of the fluorogenic peptide cleavage assays. (D) Cleavage of MIC6 fluorogenic peptide by ASP3ty and asp3ty-
D299A in the presence or absence of 49b, 49c, pepstatin and protease cocktail inhibitor. (E) Cleavage of ROP1 fluorogenic peptide by ASP3ty and
asp3ty-D299A in the presence or absence of 49b, 49c, pepstatin and protease cocktail inhibitor. (F) Quantification of peptide cleavage assays for MIC6,
ROP1, ROP13, SUB1 and MIC3 at 240 min in the presence or absence of 49b, 49c, pepstatin or protease cocktail inhibitor.
DOI: https://doi.org/10.7554/eLife.27480.031
The following source data and figure supplement are available for figure 7:
Source data 1. Source data for the in vitro cleavage assays on fluorogenic peptides for MIC6 (D), ROP1 (E), MIC6/ROP1/ROP13/SUB1/MIC3 at 240 min
(F) and RON4/MIC3 (Figure 7—figure supplement 1B).
DOI: https://doi.org/10.7554/eLife.27480.033
Figure supplement 1. In vitro cleavage assays on ASP3 putative substrates.
DOI: https://doi.org/10.7554/eLife.27480.032
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with 5% fetal calf serum (FCS), 2 mM glutamine and 25 mg/ml gentamicin. E.coli XL-10 Gold chemi-
cally competent bacteria were used for all recombinant DNA experiments.
Antibodies
The following antibodies were used in this study: T34A11 mAb anti-MIC2 (Achbarou et al., 1991),
rabbit anti-AMA1 (Lamarque et al., 2014), rabbit anti-GAP45, mAb anti-Myc (9E10), mAb anti-Ty1
(BB2), mAb anti-GRA1 (Sibley et al., 1995), rabbit anti-MIC6 (Reiss et al., 2001), rabbit anti-MIC4
(Reiss et al., 2001), mAb T52A3 anti-ROP1 (unpublished), ARO (Mueller et al., 2013), ATrx
(DeRocher et al., 2008), TLN1 (Hajagos et al., 2012), SAG1/ROP1/ROP2-4/ROP7/ROP13/RON9
(gift from Dr J-F Dubremetz), M2AP/proM2AP/CPL (gift from V. B. Carruthers), MIC3 T82C10
(Achbarou et al., 1991), MIC6 (Meissner et al., 2002), PLP1 (Roiko and Carruthers, 2013), MIC4
(Meissner et al., 2002), PfSUB1 (a gift from Michael Blackman), Cpn60 (Agrawal et al., 2009),
RON2/RON4 (gift from M. Lebrun), MIC8 (EGF-N-term) (Meissner et al., 2002).
For western blot analyses, secondary peroxidase conjugated goat a-rabbit/mouse antibodies
(Sigma) were used. For immunofluorescence analyses, the secondary antibodies Alexa Fluor 488-
and Alexa Fluor 594-conjugated goat a-mouse/rabbit antibodies (Life Technologies) were used.
Parasite transfection and selection
Transfection of T. gondii tachyzoites was performed as previously described (Soldati and Boot-
hroyd, 1993). The transgenic parasites were selected with mycophenolic acid and xanthine for
HXGPRT selection (Donald and Roos, 1993), pyrimethamine for DHFR selection (Donald and Roos,
1993) or phleomycin for Ble selection (Messina et al., 1995). Clones for all stable expressing strains
were obtained by limited dilution and checked for genomic integration by PCR and analyzed by IFA
and/or WB.
Preparation of T. gondii genomic DNA and RNA
Extraction of genomic DNA (gDNA) from T. gondii RH or RHDKu80 was done with the Wizard SV
genomic DNA purification system (Promega).
DNA vector constructs and transfection
The plasmids for generating endogenously Ty tagged strains of ASP3 was made by amplifying its C--
terminal region with primers 5000/5001 (Supplementary file 6) and cloning into pG152-KI-3Ty-lox-
SAG1_3’UTR-HX (Pieperhoff et al., 2015) between KpnI and NsiI (Supplementary file 6) to produce
the KI-ASP3ty-HX plasmid (Supplementary file 7).
The plasmids for generating endogenously tagged strains of other genes were made in a similar
fashion with appropriate primers and vectors (Supplementary files 6–8). 40 ug of linearized plas-
mids was transfected in the corresponding strains.
KI-ASP3ty-DHFR plasmid was generated by replacing the HX cassette with DHFR cassette
between SacII sites and KI-ASP3myc-Bleo plasmid was generated by subcloning the KI-ASP3 frag-
ment form KI-ASP3ty-HX plasmid into pT8-GRA7myc-Bleo (Hammoudi et al., 2015) between KpnI-
NsiI sites (Supplementary file 7).
To generate the ASP3-iKD strain, a Cas9-YFP/CRISPR gRNA targeting the 5’ region of ASP3 was
generated using the Q5 site directed mutagenesis kit (NEB) with primers 5040/4883 and using the
vector pSAG1::CAS9-GFP-U6::sgUPRT as template (Shen et al., 2014a). 5’ and 3’ homology regions
were amplified with primers 5415/5416 and 5417/5418, respectively, and cloned into the 5’COR-
pT8TATi1-HXtet07S1mycNtCOR plasmid (Salamun et al., 2014) using the sites NcoI-BamHI and
AvrII-NotI respectively. 40 ug of this plasmid was digested with Sph-SbfI and co-transfected with 20
ug of the ASP3-Cas9-YFP/CRISPR plasmid into RHDKu80. Transfected parasites were cloned by
FACS sorting the green fluorescent parasites into 96 w plates 48 hr post-transfection. Integration of
the inducible cassette was confirmed by PCR of genomic DNA using primers listed
(Supplementary file 6). ASP3 was endogenously tagged in this background, as described above,
using the KI-ASP3ty-DHFR and KI-ASP3myc-Bleo plasmids to generate the ASP3ty-iKD and
ASP3myc-iKD strains (Supplementary file 8).
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The catalytically dead mutant plasmid, pTub8-ASP3ty-D299A-HX, was generated from the
pTub8-ASP3ty-HX (Shea et al., 2007) using the Q5 site directed mutagenesis kit (NEB) with primers
5735/5736.
For complementation, Ty-tagged full length cDNA of ASP3 and its dead mutant, from pTub8-
ASP3ty-HX and pTub8-asp3ty-D299A-HX, were first cloned into a plasmid having UPRT homology
arms in both 5’ and 3’ between ApaI-PacI sites to generate 5’UPRT-pT8-ASP3ty  3’UPRT and
5’UPRT-pT8-asp3ty-D299A-3’UPRT plasmids. These plasmids were then co-transfected with 5 ug of
the UPRT-Cas9-YFP/CRISPR plasmid into the ASP3myc-iKD strain followed by FACS sorting the
green fluorescent parasites into 96 w plates 48 hr post-transfection. The integration of the cassette
was confirmed by PCR analysis on genomic DNA using primers 5994/5997.
Plasmid SUB1-Cas9-YFP/CRISPR for inserting a Ty tag before the GPI anchor of SUB1 was gener-
ated similarly to the ASP3-Cas9-YFP/CRISPR plasmid with primers 5915/4883 and transfected into
the ASP3myc-iKD strain along with 40 ug of a 130 bp double stranded oligos (5916/5917) encom-
passing the Ty tag.
In order to make the SUB2 knockout strain, part of SUB2 was replaced with a CAT cassette. We
first generated two gRNA SUB2-Cas9-YFP/CRISPR plasmids as presented (Figure 4—figure supple-
ment 4) using primers 6435/4883 and 6625/4883. Mutagenesis was done as previously described.
The second gRNA was inserted into the first plasmid between KpnI-XhoI sites to generate the SUB2-
6435-6625-Cas9-YFP/CRISPR plasmid. CAT selection cassette was amplified by KOD DNA polymer-
ase with 28 bp SUB2 homology arms in both 5’ and 3’ with primers 6626/6627 and transfected with
20 ug of the 2-guides SUB2-6435-6625-Cas9-YFP/CRISPR plasmid in the endogenously tagged
SUB2ty strain.
The plasmid for recombinant expression of MIC6 was generated by amplifying the first three EGF
domains with primers 6283/6285 and cloning it into a pET-GST vector between EcoRI-SpeI restric-
tion sites.
Transient transfection of GRASP-YFP, pTub-ASP3-3Ty and pLIC-PGRA16-GRA16-3Myc
(Hammoudi et al., 2015) was performed by using 40 mg of each plasmid as previously described
(Soldati and Boothroyd, 1993).
All primers, plasmids and strains used in this study are listed in Supplementary files 6, 7 and
8 respectively.
Immunofluorescence analysis (IFA)
HFF monolayers on coverslips were infected with T. gondii tachyzoites and grown 24–30 hr at 37˚C.
The coverslips were subsequently fixed with either cold methanol or 4% paraformaldehyde (PFA)/
0.001% glutaraldehyde (GA) for 10 min, prior to quenching with 0.1 M glycine/PBS. Cells were per-
meabilized with 0.2% Triton/PBS and blocked with 2%BSA/0.2%Triton/PBS. Following this, cells
were probed with primary antibodies diluted in 2%BSA/0.2%Triton/PBS for 1 hr followed by 3
washes with 0.2%Triton/PBS. Cells were then incubated with secondary antibodies in 2%BSA/0.2%
Triton/PBS for 1 hr. Parasite and HFF nuclei were stained with DAPI (4’,6-diamidino-2-phenylindole;
50 mg/ml in PBS) and coverslips were mounted on Fluoromount G (Southern Biotech) on glass slides
and stored at 4˚C in the dark. Images were recorded on the LSM700 confocal microscope (Zeiss) at
the Bioimaging core facility of the Faculty of Medicine, University of Geneva. Final image analysis
and processing was done with ImageJ.
Western blotting
Freshly egressed parasites were pelleted by centrifugation, washed in PBS, and subjected to SDS-
PAGE under reducing conditions. Proteins were transferred to nitrocellulose membrane and immu-
noblot analysis was performed. Primary and secondary antibodies are diluted in 5%milk/0.05%
Tween/PBS, washes are performed in 0.05%Tween/PBS.
Plaque assays
Freshly egressed parasites were inoculated on a confluent monolayer of HFFs and grown for 7 with
or without anhydrotetracycline (ATc). Parasites were fixed with PFA/GA followed by staining with
Crystal Violet as previously described.
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Invasion assay
Freshly egressed parasites pre-treated 48 hr or 24 hr +/ ATc were inoculated on coverslips seeded
with HFF monolayers and centrifuged at 1100 g for 1 min. For invasion assay with 49c, parasites
were pre-treated with DMSO/49c (1 mM) for varied time points prior to seeding them for the assay.
Invasion was allowed to take place for 20 min at 37˚C +/ ATc prior to fixation using PFA/Glu. Extra-
cellular parasites were stained first using monoclonal anti-SAG1 antibody in non-permeabilized con-
ditions. After 3 washes with PBS, cells were fixed with 1% formaldehyde/PBS for 7 min and washed
once with PBS. This is followed by permeabilization with 0.2%Triton/PBS and staining of all parasites
with polyclonal anti-GAP45 antibody. Appropriate secondary antibodies were used as previously
described. 100 parasites were counted for each experiment, and the ratio between red (all) and
green (invaded) parasites is presented. Results are mean ±standard deviation of three independent
biological replicate experiments.
Induced egress assay
Freshly egressed parasites, pre-treated 24 hr +/ ATc, were inoculated on coverslips with HFF mono-
layer and grown for 30 hr +/ ATc at 37˚C. For egress assay with 49c, parasites were pre-treated
with DMSO/49c for 12 hr prior to plating freshly egressed tachyzoites to a new monolayer of HFF
and grown for 30 hr and treatment with DMSO or 49c (1 mM) were done for varying time points. In
some cases 49c is washed away 3 hr or 6 hr before induced egress.
Following a serum-free DMEM wash, the infected HFF monolayers were incubated with 3 mM of
the Ca2+ ionophore A23187 (from Streptomyces chartreusensis, Calbiochem) in serum-free DMEM
for 7 min at 37˚C. Cells were fixed with PFA/Glu, and processed for IFA with anti-GAP45 antibody.
100 vacuoles were counted per strain and scored as egressed or non-egressed. Results are
mean ±standard deviation of three independent biological replicate experiments. Control experi-
ment with DMSO showed no egress.
For live video microscopy of induced egress, parasites were grown on 5 mm Fluorodishes (World
Precision Instruments) seeded with HFF monolayers for ~30 hr at 37˚C and egress was induced as
described above.
Microneme secretion assay
Microneme secretion assay was performed on freshly egressed parasites, with or without 24 hr/48 hr
ATc treatment or DMSO/49c (1 mM). Parasites were resuspended in equal volume of intracellular (IC)
buffer (5 mM NaCl, 142 mM KCl, 1 mM MgCl2, 2 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH to
7.2 with KOH) and pelleted at 1050 rpm for 5 min. The pellets were washed again in IC buffer before
resuspension in 100 ml serum-free media with 2% ethanol for 30 min at 37˚C. Following this incuba-
tion, parasites were pelleted at 1000 g for 5 min at 4˚C, and the supernatant was transferred to new
Eppendorf tubes (the pellet from this step serves as the pellet fraction) and re-pelleted at 2000 g for
5 min at 4˚C. The final supernatant, containing the excreted secreted antigens (ESA), and pellet frac-
tions were resuspended in SDS loading buffer and boiled prior to immunoblotting.
Evacuole formation assay
Rhoptry content secretion was assayed by means of the evacuole detection assay, as previously
described (Ha˚kansson et al., 2001; Kessler et al., 2008). Freshly egressed extracellular parasites
were incubated Endobuffer (44.7 mM K2SO4, 10 mM MgSO4, 106 mM sucrose, 5 mM glucose, 20
mM Tris–H2SO4, 3.5 mg/ml BSA, pH 8.2) containing ±1 mM Cytochalasin D for 10 min at room tem-
perature. The parasites were then added to HFF-coated coverslips, allowed to settle and incubated
at 37˚C for 15 min. The medium was replaced with complete DMEM medium containing ±1 uM
Cytochalasin D and incubated at 37˚C for an additional 20 min followed by fixation with 4% parafor-
maldehyde for 10 min. IFA was performed as described before. ROP1 is used as a rhoptry marker
for the visualisation of the evacuoles, while GAP45 was used to stain the parasites.
For analysis of MJ with RON4, 20 min permeabilization with 0.1% saponin was performed. Both
primary and secondary antibody incubations to distinguish secreted RON4 from intracellular RON4
were performed in 2%BSA/PBS. The parasite’s pellicle was stained with GAP45 antibody. 200 para-
sites were analyzed for RON4 secretion per experiment and quantified for the presence of the apical
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tip staining. The results are mean ±standard deviation of three independent biological replicate
experiments.
Intracellular growth assay
Freshly egressed parasites, pre-treated 24 hr +/ ATc, were allowed to grow on HFF monolayers
with +/ ATc for 24 hr prior to fixation with PFA/GA. For intracellular growth assay, wild type pra-
sites were seeded on HFF monolayers and were allowed to grow in the presence of DMSO/49c (0.5
mM, 1 mM, 5 mM) for 24 hr prior to fixation. IFAs were done using a-GAP45 antibodies to detect par-
asites. The number of parasites per vacuole was scored, counting 200 vacuoles for each condition.
Results are mean ±standard deviation of three independent experiments.
Gliding motility assay
Freshly egressed parasites pre-treated 48 hr +/ ATc or DMSO/49c (1 mM) were pelleted and resus-
pended in serum free DMEM before adding to poly-Lysine coated coverslips in a 24-well plate. The
plate was centrifuged for 1 min at 1100 g to settle the parasites onto the coverslips. The media is
aspirated and replaced with serum-free media containing DMSO or 3 mM A23187. Following incuba-
tion for 30 min at 37˚C, the coverslips are fixed with PFA/Glu. The deposited trails were visualized
by non-permeabilizing IFA using anti-SAG1 Abs. Results presented are representative of three inde-
pendent experiments.
Host cell attachment assay
Attachment to HFF monolayers was assessed as previously described (Mueller et al., 2013). Freshly
egressed GFP expressing WT parasites and ASP3-myc-iKD parasites (+/-ATc 48 hr or 24 hr) were
mixed in a 1:1 ratio in Endobuffer (44.7 mM K2SO4, 10 mM Mg2SO4, 106 mM sucrose, 5 mM glu-
cose, 20 mM Tris, 0.35% wt/vol BSA, pH 8.2) containing 1 mM cytochalasin D (Sigma-Aldrich). Follow-
ing 10 min incubation at room temperature, parasites were added to a HFF-coated coverslip (assay)
or Poly-L-lysine (control) and centrifuged for 1 min at 1000 rpm. Control samples were immediately
fixed with PFA/GA for 7 min at RT. For the assay samples, medium was replaced with pre-warmed
DMEM 5% FCS containing 1 mM cytochalasin D to prevent invasion, incubated for 15 min at 37˚C
and then fixed with PFA/GA for 7 min. Immunofluorescence was performed using a-GAP45 and
Alexa647 (‘red’) as secondary antibodies. Ratio between red/green (all) and red only (ASP3-myc-iKD)
attached parasites was counted. 100 parasites were screened for each condition. Results are
mean ±standard deviation of three independent experiments.
Transmission electron microscopy
Freshly egressed parasites, pre-treated 24 hr +/ ATc, were allowed to grow on HFF monolayers for
24 hr, either in the presence of 1 mM 49c or +/ ATc, prior to fixation. Infected HFFs were washed
with 0.1M phosphate buffer pH 7.2 and subsequently fixed with 2.5% glutaraldehyde in 0.1 M phos-
phate buffer pH 7.2. This is followed by post-fixation in osmium tetroxide, dehydration in ethanol
and treatment with propylene oxide before embedding in Spurr’s epoxy resin. Thin sections were
stained with uranyl actetate and lead citrate prior to examination using a Technai 20 electron micro-
scope (FEI Company). Three independent samples were prepared for each condition and multiple
thin sections were analyzed for each sample.
Protease substrate screen using terminal amine isotopic labelling of
substrates (TAILS)
ASP3 candidate substrates were identified using the methodology previously described
(Kleifeld et al., 2010; Kleifeld et al., 2011). TAILS uses primary amine labelling-based quantification
as the discriminating factor, negatively selecting non-natural N-terminal peptides by using depletion
with a dendritic polyglycerol aldehyde polymer (HPG-ALD). In addition, besides substrate protein
identification, TAILS allows mapping of cleavage sites with amino acid precision. The TAILS proce-
dure involves, tryptic digestion of the TMT labelled sample proteome (ASP3ty-iKD parasites +ATc/-
ATc), which generates internal tryptic peptides with free amines at N termini (Pre-TAILS sample).
The tryptic peptides were depleted by amine-reactive aldehyde-derivatized polymer. The unbound
peptides (TAILS sample) consist of highly enriched isotopically labelled natural and T. gondii
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processing protease-derived N-terminal peptides. This fraction is then analyzed and quantified by
high-accuracy LC-MS/MS.
Sample preparation
In brief, T. gondi protein extract was generated by treatment of cells with RIPA buffer (150 mM
NaCl, 1% NP40, 0.5% natriumdeoxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 8.0, 1 mM EDTA) for 30
min at 4˚C, high-speed centrifugation for 15 min, and subsequent acetone precipitation. The ace-
tone pellet was dissolved completely in 8M GuHCl. The sample was adjusted to 2.5 M GuHCl, 100
mM HEPES, pH 7.8 (TAILS buffer) at 2 mg/ml protein and denatured at 65˚C for 15 min. The sample
was reduced for 30 min at 65˚C in the dark by adding 0.01 volumes of 350 mM Tris (2-carboxyethyl)
phosphine (TCEP), and alkylated by addition of 0.02 volumes of 250 mM iodoacetic acid (IAA) and
incubation for 30 min at room temperature. For isobaric labeling of protein N-termini we applied
TMT10plex reagents (Thermo Scientific) at 0.8 ug/100 ug of denatured protein in 50% DMSO. A
labeling scheme is provided in the supplementary materials (Figure 3—figure supplement 1). Sub-
sequent to access label quenching by (NH4)2C03 addition (100 mM final) and reagent cleanup by
acetone-methanol precipitation, we digested proteins to peptides by adding trypsin at a 100:1 sub-
strate/enzyme ratio (w/w). Following overnight digestion, peptides having a free alpha amine were
removed from the sample by HPG-ALD polymer treatment in the presence of 20 mM NaBH3CN.
Prior to HPG-ALD polymer pullout (po) we removed 10% of the sample for separate analysis by LC-
MS (termed Pre-TAILS sample). Finally, we separated free peptides from polymer by ultra-filtration
(Amicon ultra 30 kDa, Millipore) and purified TAILS and Pre-TAILS peptides by reverse phase chro-
matography on C18 SPEs (Waters).
LC-MS analysis
Peptides were analyzed on an Orbitrap Fusion Tribrid Mass Spectrometer (Thermo Scientific) oper-
ated in line with an EASY-nLC 1000 Liquid Chromatography system (Thermo Scientific) in data
dependent analysis mode (DDA). In brief, we separated peptides by reverse phase (RP) chromatog-
raphy on custom made 150 cm x 75 mm ID frit columns packed with Reprosil-Pur 120 C18-AQ, 1.9
mm (Dr. Maisch GmbH). The liquid phase was mixed from 0.1% FA in water (A) and 0.1% FA in ACN
(B) both obtained in MS-grade from Biosolve. For separation, peptides were directly loaded onto
the analytical column and resolved by applying a linear gradient from 2% to 35% B in 120 min at a
constant flow rate of 300 nl/min. The analytical column was heated to 50˚C by an electronic column
heater for fused silica columns (PST). Eluted peptides were electrosprayed into the mass spectrome-
ter using a 10 mm PicoTip Emitter (New Objective) in combination with a Nanospray Flex Ion Source
(Thermo Scientific) operated at a spray voltage of 2.6 kV. The MS method was composed of a pre-
cursor scan (MS1) from 350 to 1250 m/z at an orbitrap resolution of 60 k (maxIT: 60 ms, AGC target:
5e5) followed by fragment ion scans (MS2) acquired post HCD activation at a collision energy of
35% in the orbitrap at a resolution of 60 k (maxIT: 118 ms, AGC target: 1e5). The first mass for all
MS2 scans was set to 100 m/z and the cycle time was limited to 2 s (top speed option). Precursors
were selected by quadrupole isolation using a window of 1.6 m/z around the respective target ion.
Target ions and their respective isotopes were excluded from fragmentation for 20 s after the 2nd
appearance within 15 s. In general, only ions of the charge state 2–5 were considered for fragment
ion spectrum recording. We preformed LC-MS data analysis using proteome discoverer 2.1 (Thermo
Scientific). In brief, we imported all LC-MS runs as fractions ignoring MS peaks below 3 S/N. Subse-
quently, we matched MS2 spectra to the Toxoplasma gondi proteome (5811 GT1) using the
SEQUEST HT search engine and the following settings: Enzyme specificity: semi-ArgC, Peptide mass
tolerance: 10 ppm, Fragment mass tolerance: 0.05 Da, Ion series: y- and b incl. neutral losses; Static
modifications: Carbamidomethyl (C) and TMT6plex (K); Variable modifications: Oxidation (M), Acety-
lation or TMT6plex (peptide n-terminus), Met-loss (protein terminus). FDR was set to 1% by the
target +decoy approach in conjunction with Percolator (Ka¨ll et al., 2007). Reporter ions were
extracted with an integration tolerance of 20 ppm. The resulting reporter ion abundance (S/N) was
normalized using the total peptide approach implemented in pd 2.1 (median normalization) and
summarized on the peptide group level applying a co-isolation threshold of 30% per matched PSM.
For further statistical analysis, we imported the Peptide Group report into the R software environ-
ment for statistical computing (version 3.3.2).
Dogga et al. eLife 2017;6:e27480. DOI: https://doi.org/10.7554/eLife.27480 25 of 35
Research article Microbiology and Infectious Disease
Parsing of datasets and interpretation
Generally speaking, abundance ratios of <1 were interpreted as proteolytic processing due to active
ASP3 in –ATc conditions, that is, higher abundance of the correctly processed (acetylated) N--
terminal peptide. Conversely, ratios >1 may be either due to higher abundance of peptides repre-
senting unprocessed N-termini or accumulation of degradation products in +ATc conditions.
However, for the purpose of identifying likely biologically relevant changes of +ATc/-ATc peptide
ratios we calculated stringent cut-offs based on the distribution of log2 ratios in the normalized pre-
TAILS dataset. Using an assumption-free empirical cumulative distribution function (ECDF) to deter-
mine the distribution of log2 ratios for R.XXXXR peptides, that is, all peptides generated by tryptic
cleavage (pre-TAILS data) cut-off ratios at the 1% and 99% quantiles were calculated. The calculated
log2 values of  0.4719 (0.72) and 0.919 (1.89), respectively, predict 1% false-positives in the dataset.
However, manual surveillance of the data indicated that a more stringent lower cut-off ratio of 0.22
was more appropriate considering that ASP3 is virtually absent in +ATc conditions. Instead of the
calculated upper cut-off (log2 0.9119) we applied a slightly more stringent threshold of 2-fold higher
abundance of peptides in +ATc conditions as secondary criterion for interpretation of the TAILS
dataset in terms of ASP3 substrate specificity. In addition, we also considered more relaxed selection
criteria with +ATc/-ATc ratio cut-off above or below 2-fold change on either side, i.e. ratios of <0.5
and>2, respectively). The criteria for substrate selection and further pertinent analysis are described
in Appendix 1.
The LC-MS-MS datasets generated in this study have been deposited on ProteomeXchange Con-
sortium via the PRIDE (Vizcaı´no et al., 2016) partner repository with the dataset identifier
PXD006235.
In vitro measurement of IC50
T. gondii tachyzoites expressing luciferase (RH-pTub-CBG99-luciferase) (200 parasites) were added
in HFF coated 96-well plate harbouring 105 cells per well. Inhibitors, (49c and 49b) along with Pyri-
methamine (used as a positive control in this experiment, Donald and Roos, 1993), were diluted in
supplemented DMEM and added to the monolayers at various concentrations in triplicates along
with DMSO treated control for each set. The assay was performed in a 100 ml final volume. The
plates were incubated for 96 hr at 37˚C, cells were washed once with PBS and lysis was performed in
the wells with 100 ml lysis buffer (20 mM Tris HCl pH 7.5, 10% Glycerol, 1% Triton X-100, 2 mM
DTT). Uninfected host cells were also lysed as negative control. 20 ml of lysate was added to 96well
MicroliteTM TCT plate and incubated with 20 mL of Luciferase substrate solution (1 mM Luciferin, 3
mM ATP, 15 mM MgSO4.7H2O, 30 mM Tris HCL pH7.5) and reading was taken immediately.
Growth of T. gondii was evaluated by measurement of relative luciferase unit (RLU) in the SynergyH1
multi-well plate reader (BioTek). Assays were performed in triplicates for each drug and IC50 (50%
reduction in luciferase activity as compared no drug treated control) were determined by plotting
luminescence against the drug concentrations from analysis of dose response curve using Prism 5.0
(GraphPad, San Diego, CA).
In vitro cleavage assays
Protease cleavage assays were performed using ASP3ty or with the catalytically dead asp3ty-D299A
immuno-purified from parasite lysates using mouse aTy antibody, as described previously
(Boddey et al., 2010; Coffey et al., 2015). Proteases bound to agarose was prepared by incubating
aTy-agarose in parasite lysate, for 2 hr at 4˚C, followed by extensive wash in 1% TritonX-100/PBS
and stored in PBS. Either 40 ul of ASP3ty or asp3ty-D299A -agarose-bound proteins were resus-
pended in digestion buffer (25 mM Tris.HCl, 25 mM MES, pH 5.5; different pH ranges were tested
and pH 5.5 was optimal) with 20 uM of synthetic peptide substrate (ThermoFisher scientific, >98%
purity) MIC6: DABCYL-G-FVQLSETPAA-G-EDANS in 100 mL of total volume. Samples were gently
shaken during incubation to disperse protease-agarose. Samples were incubated at 37˚C for 5 hr
and processing measured using a SynergyH1 multi-well plate reader (BioTek) excited at 340 nm and
reading emissions at 490 nm. Change in Relative Fluorescence Unit (DRFU) was measured for each
time point (0, 60, 120, 180, 240, 300 mins) by subtracting RFU from blank (without enzyme) for each
time point. Inhibition of ASP3 by compounds 49b (1 mM), 49c (100 nM) and pepstatin (10 mM) was
performed in exact similar manner as mentioned above by performing ASP3 cleavage assay (ASP3ty)
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in presence of each compound. The results were plotted using Prism 5.0 (GraphPad, San Diego,
CA). Cleavage assay with recombinant MIC6 was performed with approximately 1 mg of recombinant
MIC6. Recombinant MIC6 was incubated with immunoprecipitated ASP3ty or asp3ty-D299A resus-
pended in digestion buffer (50 mL total volume) for 5 hr at 37˚C with constant shaking. In some case
the assay was performed in presence of inhibitors such as Pepstatin (10 mM), 49c (1 mM) or 49b (1
mM). Samples were resuspended in SDS loading buffer and analyzed by WB witha-Profilin-GST and
a-Ty Ab.
Expression of recombinant MIC6
Recombinant MIC6 was expressed in E.coli harbouring plasmid pET-GST-MIC6, which encodes resi-
dues 15–288 of MIC6 (containing amino acid sequence 91VQLSETPA98) fused with GST in the
N-terminal.
Phylogenetic tree construction
Sequences of Apicomplexan aspartyl proteases were procured from EuPathDB and aligned using
MUSCLE sequence alignment software (Edgar, 2004a, 2004b). The resulting sequence alignment
was manually curated utilizing BioEdit (http://www.mbio.ncsu.edu/bioedit/bioedit.html) to edit out
uninformative alignment positions. Phylogeny tree was generating utilizing PhyML (Guindon et al.,
2010) on the curated MUSCLE alignment, using LG model of amino acids substitution with NNI
topology search. Phylogeny.fr (Dereeper et al., 2008) platform was utilized for much of the above
analysis. The EupathDB IDs of sequences used in the phylogenetic analysis were listed in
Supplementary file 9, and the curated alignments shown in Supplementary file 10.
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Appendix 1
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As the primary selection criterion for identifying potential ASP3 substrates we considered
peptide ratios of <0.22 or <0.5 (relaxed) representing N-termini, which are significantly less
abundant in +ATc conditions, i.e. when ASP3 activity is essentially abolished. This is true for 23
(95) peptide groups representing 17 (59) proteins, 10 (29) of which have a confirmed/
predicted signal peptide (Supplementary files 1–3). Of note, and in line with the invasion and
egress phenotypes, half of the predicted secreted proteins in these datasets are annotated in
ToxoDB as ROP, RON or MIC proteins, some of which are known to be processed in a post-
Golgi compartment.
In addition to lower abundance/disappearance of processed N-termini generated by ASP3
in +ATc conditions as a primary criterion for identifying ASP3 substrates, we also identified 42
peptide groups with +ATc/-ATc ratios >2 representing 29 proteins, 21 of which have a
predicted signal sequence (Supplementary file 3, Figure 2C). Because ASP3 is an essential,
post-Golgi resident processing enzyme, we reasoned that parasite growth in +ATc conditions
might lead to a general perturbation of their distal secretory system resulting in an increased
occurrence of N-terminal peptides representing degradation products. More importantly, this
also predicts that unprocessed direct or indirect ASP3 substrates may be subject to an
increased rate of degradation eliciting increased proportions of tryptic peptides that are not
represented in –ATc conditions. Indeed, by intersecting both datasets, we identified 5 (8)
proteins (Supplementary file 4, Figure 2C), which are represented by peptides with strongly
polarized +ATc/-ATc ratios. Using relaxed criteria this set comprises SUB1, MIC3, MIC11,
ROP9, ROP16, and ROP40, as well as two hypothetical transmembrane proteins of unknown
function and localization. While we consider this as robust support for candidate ASP3
substrates, the 17 remaining secreted proteins in the curated TAILS dataset represented only
by peptides with a ratio <0.5 are also considered valid candidate substrates (Figure 2C). In
addition, considering that N-termini may not be detected in the LC-MS-MS analysis for purely
technical reasons (cleavage generates peptides incompatible with LC-MS analysis due to
peptide length, charge state or hydrophobicity), this leaves the possibility that some ASP3
substrates are represented only by peptides with a ratio >2, that is, putative degradation
products.
The most robust indication for directly ASP3-dependent processing events are +ATc/-ATc
ratios of <0.22 (0.5) for N-terminal peptides in conjunction with the detection of additional
peptides representing immature or degraded products with ratios >2. While this is the case
for some examples such as MIC3 or MIC11, many of the 12 (39) proteins represented only by
the former require additional evaluation. Experimentally validated ASP3 substrates provide an
excellent framework for interpreting TAILS datasets. MIC3 is a classic case of experimentally
validated posttranslational processing represented in TAILS. The MIC3 N-terminal peptide [F].
AVTETHSSVQSPSKQETQLCAISSEGKPCR.[N] (57–869 has an acetyl modification at the
N-terminal alanine and an +ATc/-ATc ratio of 0.074 which is 3-fold lower than the stringent
cutoff of <0.22. A second, non-acetylated N-terminus at S67 is also represented with a
peptide ratio of 0.079. Prima facie the former would be considered the more likely mature
N-terminus of the processed ASP3 substrate. However, if normalized abundances are taken
into account it becomes clear that the latter is represented with a >100 fold higher abundance
(Supplementary file 5, Line 35, Columns AO-AR). Although a minor proportion of MIC3 is
processed at position S69 there is no indication in the TAILS dataset that this is due to
technical reasons and therefore likely represents a natural variability. Taken together, both
qualitative and quantitative parameters of the TAILS data are in complete agreement with the
predicted cleavage site at [SSVQ | SPSK] and in support of MIC3 being an ASP3 substrate.
MIC11 provides another, albeit non-validated example presenting a very similar profile in
TAILS. A highly abundant N-terminal peptide [T].EDDKSAASIVR.[G] (58-68) with a ratio of
0.045 robustly predicts an ASP3-dependent cleavage site in this 204 aa protein at [VETT |
EDDK]. Here too, detection of an N-terminal peptide shifted by two amino acids (56-68) with
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a ~15 fold lower abundance likely represents a minor alternative cleavage site. In addition,
four peptides with ratios >2 were detected, one of which is highly abundant in +ATc
conditions and likely represents an immature N-terminus after cleavage of the signal peptide.
Some ASP3 substrates may be revealed in the TAILS dataset only by peptides with
ratios <0.22 (0.5). This is the case for MIC6 whose predicted ASP3 cleavage site [VQLS | ETPA]
is represented by the abundant peptide [S].ETPAACSSNPCGPEAAGTCKETNSGYICR.[C] with
an +ATc/-ATc ratio of 0.089 in the TAILS dataset. No peptides with ratios >2 have been
detected in this experiment. ASP3-dependent processing of MIC6 has been experimentally
validated (Figure 3B), as well as for the hypothetical protein TGGT1_273860 (TAILS3)
(Figure 5A), which presents a very similar profile in TAILS analysis. Conversely, ROP1 was only
represented by peptides with +ATc/-ATc ratios >2 in the TAILS dataset. Nevertheless, in vitro
cleavage experiments show ASP3-dependent processing producing a mature protein of ~55
kDa (Figure 4A). Although two acetylated N-termini were detected in MS analysis, in this case,
likely for technical reasons (e.g. flyability), the quantitative information was not sufficient to
calculate peptide abundances. However, the high number of peptides (4 N-terminal, 5
internal) in the TAILS profile with ratios >2 is consistent with ROP1 being an ASP3 substrate.
Taken together, TAILS allowed efficient (albeit not comprehensive) identification of ASP3
substrates by interpretation of +ATc/-ATc peptide ratios, and provided biochemical
information on processed N-termini.
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